C Weil, M W Parsons, J Chipman, R D Kraus, G Suneja, L M Burt, R Dood, D K Gaffney
PURPOSE/OBJECTIVE(S): Survivors of cervical cancer who received chemotherapy and/or radiation therapy (RT) are at an increased lifetime risk of secondary malignancy (SM). We sought to characterize the risk of SM, stratified by treatment modality, radiation technique, age and time since diagnosis. MATERIALS/METHODS: Utilizing the National Cancer Institute's Surveillance, Epidemiology and End Results Program database, we identified 42,359 patients representing 496,590 patient years with cervical cancer as first diagnosis between 1975 and 2016...
November 1, 2021: International Journal of Radiation Oncology, Biology, Physics